How Is Rising Healthcare Expenditure Fueling Nebulizer Demand?

ALBANY, Calif. - May 2, 2022 - PRLog -- The World Health Organization (WHO) estimates that chronic obstructive pulmonary disease (COPD) caused nearly 3.23 million deaths in 2019. Of these, approximately 80% of the fatalities occurred in low- and middle-income countries (LMICs). As per the organization, COPD is the third-leading cause of global deaths. Individuals suffering from COPD use nebulizers to get some relief; thus, the escalating cases of COPD will propel the adoption of nebulizers in the foreseeable future.

Nowadays, clinics, emergency centers, and hospitals and ambulatory surgical centers are using portable and stand-alone nebulizers for people suffering from various respiratory diseases. In the coming years, portable nebulizers will be adopted at the faster pace due to the mounting geriatric population and burgeoning demand for convenient treatment. Portable and non-portable pneumatic, mesh, and ultrasonic nebulizers are being used by end users to offer relief to their patients. Among these variants, pneumatic nebulizers will be used at the highest rate in the foreseeable future due to their durability, better dosage control, lower drug wastage, and particle size flexibility.

According to P&S Intelligence, North America procured the largest number of nebulizers in the preceding years due to the high prevalence of respiratory diseases and extensive healthcare expenditure. According to the Centers for Disease Control and Prevention (CDC), chronic lower respiratory diseases accounted for 156,979 human fatalities in the U.S. in 2019. Furthermore, the CDC states that bronchitis and emphysema caused 448 and 7,272 deaths, respectively, in the U.S. in 2019. Moreover, the surging introduction of new products will fuel the usage of nebulizers in the region.

Whereas, the Asia-Pacific (APAC) nebulizer market (https://www.psmarketresearch.com/market-analysis/nebulize...) is expected to demonstrate the fastest growth during the forecast period due to the booming demand for generic nebulizable drugs, soaring population of tobacco smokers, mounting air pollution levels, and escalating healthcare expenditure in the region. India, China, and Japan have a vast population of cigarette smokers, owing to which the region is witnessing an extensive surge in the cases of respiratory diseases, thereby augmenting the demand for nebulizers.

Thus, the rising incidence of respiratory diseases and mounting healthcare expenditure will propel the usage of nebulizers.